Moderna Therapeutics (Not covered): The new year begins with another huge deal!
Moderna Therapeutics announced an exclusive strategic agreement with Alexion to develop and commercialize pioneering messenger RNA therapeutics™ for the treatment of Rare diseases. Following the two deals already signed in 2013 with AstraZeneca and US army DARPA, Moderna is confirming the breakthrough potential of its mRNA Therpeutics platform.
Full report available to subscribers
Please contact firstname.lastname@example.org